cenyx biotech seunghoon lee

Foreigners and institutional investors in the South Korean stock market picked biotechs as their favorite shares in hopes of a biopharma stock jump ...

South Korea’s Sapien Semiconductors Inc. is a lesser-known startup outside of the chip industry. However, it is a little giant in the fabless ...

Lee Jae-hyun, who has led one of Samsung Securities Co.'s investment banking divisions for two years, has recently expressed his intention to quit, ...

Samsung Electronics Co. Chairman Jay Y. Lee on Thursday visited India for the wedding of Anant Ambani — the youngest son of Asia’s riche...

Samsung C&T Corp., its bio units Samsung Biologics Co. and Samsung Bioepis Co. and Samsung Venture Investment Corp. have committed a combined 72...

Samsung Group is on track to rise to the top of biosimilar companies in the world and become South Korea’s largest drug maker for contract man...

Hyundai Glovis Co., the logistics unit of South Korea’s Hyundai Motor Group, said on Friday it will spend 9 trillion won ($6.5 billion) throug...

The eldest daughter of catering service provider Ourhome Ltd.’s founding family, Koo Mi-hyun, was on Tuesday appointed chief executive of the ...

South Korea’s bio and tech-heavy Kosdaq-listed Shaperon Inc. raised 12.7 billion won ($9.2 million) from its latest rights offering, selling o...

South Korean biotech Bertis Inc. will deliver presentations at the BIO International Convention, one of the world’s largest bio and healthcare...

HLB Co. and its affiliate stocks tumbled on Friday on news that the South Korean biotech group’s highly anticipated new cancer treatment Rivoc...

South Korean biotech Xcell Therapeutics Inc., a developer of chemically defined media for in vitro cell culture, is aiming for a junior bourse Kosda...

Macquarie Group has named two executives at its Seoul-based real asset investment unit, which manages the main Kospi-listed Macquarie Korea Infrastr...

Samsung Life Science Fund, managed by Samsung Group’s venture investment arm, has invested in US biotechnology firm Latus Bio Inc. during the ...

Samsung Electronics Co. is deepening ties with Zeiss Group, the sole provider of optical systems to the world’s only extreme ultraviolet (EUV)...

South Korea named John Lee, a former senior executive of the US National Aeronautics and Space Administration (NASA), as the head of missions such a...

Samsung Group heiress and Hotel Shilla Chief Executive Lee Boo-jin sold 441.2 billion won ($325.9 million) worth of Samsung Electronics Co. shares i...

South Korea’s Military Mutual Aid Association (MMAA), which managed 10.4 trillion won ($7.7 billion) in assets as of the end of 2023, said on ...

K-pop pioneer SM Entertainment Co.'s founder and former Chief Producer Lee Soo-man is expected to invest up to 10 billion won ($7.5 million) in Mind...

Mark Zuckerberg, chief executive of US tech giant Meta Platforms Inc. plans to visit South Korea later this month and meet key figures including Pre...

Samsung Biologics Co. has agreed with South Korean biotech company LegoChem Biosciences Inc. to provide contract development organization (CDO) serv...

Samsung Electronics Co. Chairman Jay Y. Lee has embarked on a business trip to the Middle East in his first overseas trip since a South Korean court...

Cleared of wrongdoing charges that shackled his leadership for years, Samsung Group leader Jay Y. Lee now will actively seek mergers and acquisition...

The Seoul Central District Court on Monday acquitted Samsung Electronics Co. Chairman Jay Y. Lee of charges of being involved in illegal activities ...

South Korea’s snack and confectionery maker Orion Group has agreed to buy a controlling stake in LegoChem Biosciences Inc., a Korean biotech s...

Samsung C&T Corp., Samsung Biologics Co. and Samsung Bioepis Co. will ramp up investments in US biotechnology startups in collaboration with Fla...

SEOUL—South Korea beefed up security for prominent political figures as new threats of violence materialized against top officials, including ...

LegoChem Biosciences Inc. has signed a blockbuster $1.7 billion deal to license out its proprietary antibody drug conjugate (ADC) candidate to Jasse...

South Korean clinical-stage biotech D&D Pharmatech Inc. has won approval from the Korea Exchange’s preliminary review for listing on the j...

Viva Republica Inc., the operator of South Korea’s fintech platform Toss, has revived plans to go public after pushing back its stock market d...